Risk factors, and outcomes of patients with carbapenem-resistant Enterobacterales bloodstream infection: an eight-year case-case-control study
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2025.1734801 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Haifang Kong und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Tianjin Medical University General Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Enterobacteriaceae Infections, Carbapenems, Bacteremia, Anti-Bacterial Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Carbapenem-resistant Enterobacterales bloodstream infection (CRE-BSI) represents a major and urgent challenge to global public health. Some patients with CRE-BSI have a greater risk for poor clinical outcomes, thus identifying risk factors for CRE-BSI is required to determine the most at-risk populations. Here, we investigated risk factors for CRE-BSI by conducting a retrospective case-case-control study at Tianjin Medical University General Hospital, between 2017 and 2024. A total of 144 patients with CRE-BSI were enrolled in this case-case-control study. Each case was matched simultaneously to a patient with carbapenem-susceptible Enterobacterales BSI (CSE-BSI) and a control patient with non- Enterobacterales bacteremia in a 1:1:1 ratio. This design facilitated the analysis of risk factors and a comparison of 30-day survival outcomes among groups. Multivariable logistic regression identified distinct risk factor profiles for different infections. Surgical history emerged as an independent risk factor for Enterobacterales -BSI. Independent risk factors for CRE-BSI encompassed prior exposure to third-generation cephalosporins (OR = 1.94), carbapenems (OR = 3.45), quinolones (OR = 2.54), and glucocorticoids (OR = 2.55), in addition to a history of surgery (OR = 2.44) and gastric tube insertion (OR = 2.45). In-hospital mortality for CRE-BSI reached 52.8%. Furthermore, arterial catheter use (OR = 2.50) was identified as an independent risk factor for in-hospital mortality in patients with CRE-BSI. Cox proportional hazards modeling revealed several independent predicators of 30-day mortality: patient group (HR = 1.37; 95% CI, 1.01–1.86; p = 0.04), age ≥ 65 years (HR = 0.43; 95% CI, 0.20–0.93; p = 0.03), respiratory diseases (HR = 3.17; 95% CI, 1.54–6.51; p = 0.002), and digestive system diseases (HR = 1.79; 95% CI, 1.03–3.10; p = 0.04). Thus, a comprehensive evaluation of underlying diseases, antibiotic usage, and invasive procedures is required to reduce CRE-BSI-associated mortality. Given the notable morbidity and mortality, as well as constrained therapeutic options, associated with CRE-BSI, identifying risk factors for CRE-BSI is urgently required for effective disease prevention and to develop novel therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Tianjin Medical University General Hospital, Tianjin, China.
- Department of Neurosurgery, Huanhu Hospital Affiliated to Tianjin Medical University, Tianjin, China.
- Tianjin Key Laboratory of Cerebral Vascular and Neurodegenerative Diseases, Tianjin Neurosurgical Institute, Tianjin Huanhu Hospital,Tianjin, China.
- Qingdao Eighth People's Hospital, Shandong, China.
- Department of Neurosurgery, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
- The Fourth Central Hospital Affiliated to Tianjin Medical University, Tianjin, China.
Zitieren
APA
Kong, H., Liu, Y., Wang, Y., Yang, L., Chen, Q., Li, Y., Dong, Z., Hu, Z., Chai, Y., Wang, X., & Yan, H. (2026). Risk factors, and outcomes of patients with carbapenem-resistant Enterobacterales bloodstream infection: an eight-year case-case-control study. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1734801
Vancouver
Kong H, Liu Y, Wang Y, Yang L, Chen Q, Li Y, et al. Risk factors, and outcomes of patients with carbapenem-resistant Enterobacterales bloodstream infection: an eight-year case-case-control study. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2025.1734801
BibTeX
@article{Kong2026,
author = {Kong, Haifang and Liu, Yong and Wang, Yaqing and Yang, Ling and Chen, Qianqian and Li, Yanchun and Dong, Zuoliang and Hu, Zhidong and Chai, Yamin and Wang, Xiuyu and Yan, Hua},
title = {Risk factors, and outcomes of patients with carbapenem-resistant Enterobacterales bloodstream infection: an eight-year case-case-control study},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2025.1734801}
}
EUVIMED